Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 7, 2021
Open Peer Review Period: Apr 7, 2021 - Jun 2, 2021
Date Accepted: Sep 17, 2021
Date Submitted to PubMed: Nov 30, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation

Abdelkader W, Navarro T, Parrish R, Cotoi C, Germini F, Linkins LA, Iorio A, Haynes RB, Ananiadou S, Chu L, Lokker C

A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation

JMIR Res Protoc 2021;10(11):e29398

DOI: 10.2196/29398

PMID: 34847061

PMCID: 8669577

A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles from The Biomedical Literature: A Study Protocol

  • Wael Abdelkader; 
  • Tamara Navarro; 
  • Rick Parrish; 
  • Chris Cotoi; 
  • Federico Germini; 
  • Lori-Ann Linkins; 
  • Alfonso Iorio; 
  • R. Brian Haynes; 
  • Sophia Ananiadou; 
  • Lingyang Chu; 
  • Cynthia Lokker

ABSTRACT

Background:

A barrier to practicing evidence-based medicine is the rapidly increasing body of biomedical literature. Use of method terms to limit the search can help reduce the burden of screening articles for clinical relevance, however, it is limited by their partial dependence on indexing terms and usually produces low precision, especially when high sensitivity is required. Machine learning has been applied to the identification of high-quality literature with the potential to achieve high precision without sacrificing sensitivity. The use of artificial intelligence has shown promise to improve efficiency for identifying sound evidence.

Objective:

The primary objective of this research is to derive and validate deep learning machine models using iterations of Bidirectional Encoder Representations from Transformers (BERT) to retrieve high-quality, high relevance evidence for clinical consideration from the biomedical literature.

Methods:

Using the HuggingFace transformers library, we will experiment with variations of BERT models, including BERT, BioBERT, BlueBERT, and PubMedBERT, to determine which have the best performance in article identification based on quality criteria. Our experiments will utilize a large dataset of over 150,000 PubMed citations which have been manually labeled based on their methodological rigor for clinical use. We will evaluate and report on the performance of the classifiers in categorizing articles based on their likelihood of meeting quality criteria.

Results:

Model performance characteristics will include recall (sensitivity), specificity, precision, accuracy, F-score, and classification probability scores.

Conclusions:

The experiments will be devised to improve the precision of the retrieval of high-quality articles by applying a machine learning classifier to PubMed searching.


 Citation

Please cite as:

Abdelkader W, Navarro T, Parrish R, Cotoi C, Germini F, Linkins LA, Iorio A, Haynes RB, Ananiadou S, Chu L, Lokker C

A Deep Learning Approach to Refine the Identification of High-Quality Clinical Research Articles From the Biomedical Literature: Protocol for Algorithm Development and Validation

JMIR Res Protoc 2021;10(11):e29398

DOI: 10.2196/29398

PMID: 34847061

PMCID: 8669577

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.